Abstract:Apoptosis is one of the main types of programmed cell deaths(PCD)and involves a series of biochemical events that lead to a variety of morphological changes and death.The initial and progress of apoptosis is precisely regulated.This review will summarize current knowledge of the signal transduction pathways of apoptosis.It is now well-established that the apoptotic signals generally involve the extrinsic or intrinsic pathways of apoptosis.The extrinsic pathway originates at the membrane and engages cell surface receptors whereas the intrinsic pathway predominantly involves mitochondria.In the intrinsic pathway,the cell signal induced changes of mitochondrial membrane permeability and the loss of membrane potential.Many proteins factors released,and then cytoplasmic cytochrome C and caspase-9 form of apoptosis.The activated caspase-9 cut caspase-3,then cell dead at last.In the case of extrinsic pathway,several receptors exist including Fas,TNFR-1,DR3,DR4,DR5 and DR6.These receptors contain an intracellular region of approximately 80 amino acids that is designated as death domain.The domain is an important structure that plays a key role in the transduction of apoptotic signals.The interaction between Fas and its ligand(FasL)triggers the formation of a death-inducing signaling complex(DISC),which subsequently recruits and activates caspase-8;this in turn activates other procaspases and culminates in the cleavage of cellular substrates and apoptosis.During the process of tumor cell lines apoptosis Inducted by chemotherapy.It is easy to see the increasing of the Fas receptors and inducing of FasL expression,it can inhibite apoptosis when the blocking Fas /FasL.Tumor necrosis factor(TNF)-related apoptosis-inducing ligand(TRAIL)is a type II transmembrane protein belonging to the TNF family of ligands.TRAIL has been suggested as a safe and tumorselective anticancer agent with low toxicity to normal tissues,and is thought to play a role in tumor immune surveillance by NK,T cells and

Research and Applicatuon of Death Receptor 5-Mediated Apoptosis

TRAIL and Cancer Therapy

Molecular Mechanisms of Resistance to TRAIL-induced Apoptosis in Tumor

Advance Research in Apoptosis Mediating by Death Receptor

Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells

Research Advance in TNF Related Apoptosis Inducing Ligand

Small-molecule Activation of the TRAIL Receptor DR5 in Human Cancer Cells

Developing TRAIL/TRAIL death receptor-based cancer therapies

Mechanism of TRAIL Induced Tumor Cell Apoptosis and Application of TRAIL Based on Tumor Therapy

Death Receptor 5 Promotes Tumor Progression in Gastric Cancer.

The Investigation of the Relationship Between Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Tumor Therapy

The Progress of Research on The Relationship Between TRAF6 and Apoptosis

Characterization of a Novel Anti-DR5 Monoclonal Antibody WD1 with the Potential to Induce Tumor Cell Apoptosis

Structural Basis of LaDR5, a Novel Agonistic Anti-Death Receptor 5 (DR5) Monoclonal Antibody, to Inhibit DR5/TRAIL Complex Formation

Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling

TNF-related Apoptosis-Inducing Ligand and Tumor

Analysis of aDR5scFv with Specific Identification and Function.

A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity in Vitro and in Vivo

Induction of Apoptosis in U343 Cell Line by a Novel Anti-Human DR5 Monoclonal Antibody

Molecular Mechanisms of TRAIL-induced Apoptosis of Cancer Cells

Apoptotic and Antitumor Activity of Death Receptor Antibodies Require Inhibitory Fcγ Receptor Engagement.